Genmab A/S
GMAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001434265
No open-market purchases or sales by Genmab A/S insiders were filed in the last 90 days; 291 institutions reported holding it in 13F filings for Q2 2026, worth $2.81B in total; no superinvestor holds it.
Other share classesGNMSF
13F holders, Q4 2023
Institutional positions in Genmab A/S as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 226
- −3 vs. Q3 2023
- Shares held
- 46.6M
- −717.3K (−1.5%) vs. Q3 2023
- Total value
- $1.48B
- −$192.6M (−11.5%) vs. Q3 2023
- New holders
- 43
- 54 more added
- Sold out
- 46
- 103 more reduced
5 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GMAB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 291 | $2.81B |
| Q1 2026 | 275 | $2.23B |
| Q4 2025 | 293 | $2.26B |
| Q3 2025 | 253 | $1.89B |
| Q2 2025 | 218 | $1.32B |
| Q1 2025 | 220 | $1.27B |
| Q4 2024 | 230 | $1.27B |
| Q3 2024 | 224 | $1.27B |
| Q2 2024 | 220 | $1.23B |
| Q1 2024 | 227 | $1.43B |
| Q4 2023 | 226 | $1.48B |
| Q3 2023 | 234 | $1.67B |
| Q2 2023 | 214 | $1.59B |
| Q1 2023 | 217 | $1.62B |
| Q4 2022 | 238 | $1.94B |
| Q3 2022 | 194 | $1.43B |
| Q2 2022 | 181 | $1.15B |
| Q1 2022 | 204 | $1.41B |
| Q4 2021 | 212 | $1.58B |
| Q3 2021 | 213 | $1.89B |
| Q2 2021 | 213 | $1.89B |
| Q1 2021 | 211 | $1.37B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Genmab A/S; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Natixis Advisors, L.P. | 187,798 | $5.98M | 0.02% | −41,099−18.0% | Reduced |
| Price T Rowe Associates Inc | 189,491 | $6.03M | 0.00% | −11,227−5.6% | Reduced |
| Raymond James & Associates | 191,154 | $6.09M | 0.00% | −5,405−2.7% | Reduced |
| Cubist Systematic Strategies, LLC | 212,446 | $6.76M | 0.08% | +181,699+590.9% | Added |
| Marshall Wace, LLP | 215,408 | $6.86M | 0.01% | +4,609+2.2% | Added |
| Royal London Asset Management Ltd | 227,054 | $7.23M | 0.02% | −26,451−10.4% | Reduced |
| Qube Research & Technologies Ltd | 257,116 | $8.19M | 0.02% | +127,109+97.8% | Added |
| FMR LLC | 267,505 | $8.52M | 0.00% | −154,932−36.7% | Reduced |
| American Century Companies Inc | 456,422 | $14.5M | 0.01% | +5,914+1.3% | Added |
| Hardman Johnston Global Advisors LLC | 482,657 | $15.4M | 0.49% | −109,661−18.5% | Reduced |
| Millennium Management LLC | 512,281 | $16.3M | 0.02% | +371,068+262.8% | Added |
| Goldman Sachs Group Inc | 527,924 | $16.8M | 0.00% | −108,410−17.0% | Reduced |
| Northern Trust Corp | 539,030 | $17.2M | 0.00% | −20,014−3.6% | Reduced |
| Wells Fargo & Company | 557,132 | $17.7M | 0.01% | −32,261−5.5% | Reduced |
| Royal Bank of Canada | 640,989 | $20.4M | 0.01% | −194,821−23.3% | Reduced |
| Stifel Financial Corp | 672,893 | $21.4M | 0.03% | −35,216−5.0% | Reduced |
| Bank of America Corp | 889,164 | $28.3M | 0.00% | −23,123−2.5% | Reduced |
| Envestnet Asset Management Inc | 925,918 | $29.5M | 0.01% | −20,962−2.2% | Reduced |
| Morgan Stanley | 1,089,097 | $34.7M | 0.00% | −11,422−1.0% | Reduced |
| First Trust Advisors LP | 1,270,095 | $40.4M | 0.04% | +175,292+16.0% | Added |
| Renaissance Technologies LLC | 1,494,800 | $47.6M | 0.07% | +320,800+27.3% | Added |
| Wellington Management Group LLP | 2,369,331 | $75.4M | 0.01% | −56,050−2.3% | Reduced |
| Harding Loevner LP | 3,289,895 | $97.6M | 0.55% | +85,665+2.7% | Added |
| Capital International Investors | 4,057,922 | $129.7M | 0.03% | −260,420−6.0% | Reduced |
| BlackRock Inc. | 4,409,575 | $140.4M | 0.00% | −407,844−8.5% | Reduced |
| Alliancebernstein L.P. | 15,614,510 | $497.2M | 0.19% | +6,099,301+64.1% | Added |
| 1832 Asset Management L.P. | 0 | $0 | 0.00% | −2,243,600−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −226,802−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −212,522−100.0% | Sold out |
| First Light Asset Management, LLC | 0 | $0 | 0.00% | −157,147−100.0% | Sold out |
| Aquilo Capital Management, LLC | 0 | $0 | 0.00% | −52,148−100.0% | Sold out |
| Azzad Asset Management Inc | 0 | $0 | 0.00% | −47,713−100.0% | Sold out |
| Capricorn Fund Managers Ltd | 0 | $0 | 0.00% | −37,007−100.0% | Sold out |
| Ativo Capital Management LLC | 0 | $0 | 0.00% | −28,442−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −26,552−100.0% | Sold out |
| Navellier & Associates Inc | 0 | $0 | 0.00% | −25,600−100.0% | Sold out |
| Cim, LLC | 0 | $0 | 0.00% | −24,268−100.0% | Sold out |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0 | $0 | 0.00% | −23,704−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −18,651−100.0% | Sold out |
| Genus Capital Management Inc. | 0 | $0 | 0.00% | −10,775−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −10,629−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −9,824−100.0% | Sold out |
| Syon Capital LLC | 0 | $0 | 0.00% | −9,414−100.0% | Sold out |
| CI Private Wealth, LLC | 0 | $0 | 0.00% | −9,020−100.0% | Sold out |
| Vident Advisory, LLC | 0 | $0 | 0.00% | −8,262−100.0% | Sold out |
| McKinley Capital Management LLC /Delaware | 0 | $0 | 0.00% | −8,058−100.0% | Sold out |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −7,695−100.0% | Sold out |
| Evergreen Capital Management LLC | 0 | $0 | 0.00% | −7,420−100.0% | Sold out |
| Harbour Capital Advisors, LLC | 0 | $0 | 0.00% | −7,168−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −7,112−100.0% | Sold out |
| FDx Advisors, Inc. | 0 | $0 | 0.00% | −7,007−100.0% | Sold out |
| Guggenheim Capital LLC | 0 | $0 | 0.00% | −6,563−100.0% | Sold out |
| Mount Yale Investment Advisors, LLC | 0 | $0 | 0.00% | −6,390−100.0% | Sold out |
| Transatlantique Private Wealth LLC | 0 | $0 | 0.00% | −6,271−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −6,268−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −6,021−100.0% | Sold out |
| Greenleaf Trust | 0 | $0 | 0.00% | −6,018−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −5,826−100.0% | Sold out |
| Snowden Capital Advisors LLC | 0 | $0 | 0.00% | −5,721−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −4,686−100.0% | Sold out |
| Laffer Tengler Investments | 0 | $0 | 0.00% | −1,974−100.0% | Sold out |
| Covestor Ltd | 0 | $0 | 0.00% | −853−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −772−100.0% | Sold out |
| FinTrust Capital Advisors, LLC | 0 | $0 | 0.00% | −364−100.0% | Sold out |
| Harvest Fund Management Co., Ltd | 0 | $0 | 0.00% | −166−100.0% | Sold out |
| Front Row Advisors LLC | 0 | $0 | 0.00% | −145−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −124−100.0% | Sold out |
| Bokf, NA | 0 | $0 | 0.00% | −145−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −88−100.0% | Sold out |
| Macroview Investment Management LLC | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Fisher Asset Management, LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| International Biotechnology Trust PLC | – | – | – | – | Not filed |
| First Republic Investment Management, Inc. | – | – | – | – | Not filed |
| Advisor Partners II, LLC | – | – | – | – | Not filed |
| Column Capital Advisors, LLC | – | – | – | – | Not filed |
| Steward Financial Group LLC | – | – | – | – | Not filed |